Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Menorrhagia 7Leiomyoma 7Polycystic Ovary Syndrome 1

Interventions

Inositol 6follitropin alfa 4Glycoprotein Hormones, alpha Subunit 3follitropin beta 2Metformin 2Letrozole 2DLBS3233 2Clomiphene 2Chorionic Gonadotropin 2licogliflozin 1elagolix 1cetrorelix 1Urofollitropin 1Secretome 1Progesterone 1Oils 1Menotropins 1Leuprolide 1Lactalbumin 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Itraconazole 1Folic Acid 1Diosgenin 1Contraceptives, Oral 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Polycystic Ovary Syndrome × elagolix × Clear all
NCT03951077 2022-06-08

Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome

AbbVie

Phase 2 Completed
118 enrolled 13 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡